References
The End of Alzheimer’s Program – Dale E. Bredesen, M.D. References
Following is a list of references from the book, The End of Alzheimer’s Program, published by Avery/Random House. Due to the length of the text, these references could not be included in the print version, and therefore are listed below.
1 – Yifan Wu et al., Nature Communications 10, 58, December 2019
Microglia and Amyloid Precursor Protein Coordinate Control of Transient Candida Cerebritis with Memory Deficits
2 – Surjyadipta Bhattacharjee et al., Journal of Inorganic Biochemistry 126, 35–37, September 2013
Selective Accumulation of Aluminum in Cerebral Arteries in Alzheimer’s Disease (AD)
3 – Nicolas M. Vogt et al., Scientific Reports 7, 13537, December 2017
Gut Microbiome Alterations in Alzheimer’s Disease
4 – Taoufiq Harach et al., Scientific Reports 7, 41802, February 2017
Reduction of Abeta Amyloid Pathology in APPPS1 Transgenic Mice in the Absence of Gut Microbiota
5 – Laura Bonfili et al., Scientific Reports 7, 2426, May 2017
Microbiota Modulation Counteracts Alzheimer’s Disease Progression Influencing Neuronal Proteolysis and Gut Hormones Plasma Levels
6 – Laura Bonfili et al., Molecular Neurobiology 55, no. 10, 7987–8000, October 2018
SLAB51 Probiotic Formulation Activates SIRT1 Pathway Promoting Antioxidant and Neuroprotective Effects in an AD Mouse Model
7 – Li Wen and Andrew Duffy, Journal of Nutrition 147, no. 7, 1468S–75S, June 2017
Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes
7 – Yasmine Belkaid and Timothy Hand, Cell 157, no. 1, 121–41, March 2014
Role of the Microbiota in Immunity and Inflammation
8 – William R. Wikoff et al., Proceedings of the National Academy of Sciences 106, no. 10, 3698–703, March 2009
Metabolomics Analysis Reveals Large Effects of Gut Microflora on Mammalian Blood Metabolites
9 – Christensen,L., Ascent2health.com, 2017